Cemiplimab-Associated Sinusoidal Obstruction Syndrome
Open Access
- 1 April 2023
- journal article
- research article
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 10 (4) , e01038
Abstract
A 58-year-old woman developed new-onset recurrent ascites after the recent initiation of cemiplimab for the treatment of advanced basal cell carcinoma. A comprehensive serological workup for viral, metabolic, and autoimmune causes was unrevealing. Transjugular liver biopsy demonstrated parenchymal changes consistent with a diagnosis of sinusoidal obstruction syndrome. While this is a condition commonly observed in patients after hematopoietic stem cell transplantation or use of chemotherapeutic agents, it should also be considered in patients who develop new-onset liver dysfunction after the initiation of checkpoint inhibitors.Keywords
This publication has 15 references indexed in Scilit:
- Epigenetic Mechanisms of Resistance to Immune Checkpoint InhibitorsBiomolecules, 2020
- Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell TransplantationFrontiers in Immunology, 2020
- Hepatobiliary and Pancreatic: Biliary injury related to checkpoint inhibitor “pembrolizumab”Journal of Gastroenterology and Hepatology, 2019
- Nodular Regenerative Hyperplasia Associated With Immune Checkpoint BlockadeHepatology, 2018
- Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow TransplantationBone Marrow Transplantation, 2016
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodiesAnnals of Oncology, 2015
- G-CSF increases the expression of VCAM-1 on stromal cells promoting the adhesion of CD34+ hematopoietic cells: studies under flow conditionsExperimental Hematology, 2004
- Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levelsTransplantation Proceedings, 2004
- Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: The role of glutathione and relevance to hepatic venoocclusive diseaseHepatology, 1996
- Cyclosporin-induced endothelial cell injury.1986